Afinitor (everolimus)

pCPA File Number: 20766
Negotiation Status:
Concluded with an LOI
Indication(s):
Pancreatic Neuroendocrine Tumors
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
pCODR 10007
pCPA Engagement Letter Issued:
Negotiation Process Concluded: